Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“Substantial” Device Effectiveness Proposed As Coverage Decision Category

This article was originally published in The Gray Sheet

Executive Summary

CMS will allow the Medicare Coverage Advisory Committee to designate a new effectiveness category for devices showing a "substantial clinical benefit" over existing technologies, Acting Chief Clinical Officer Sean Tunis indicated Sept. 25

You may also be interested in...



Draft Guidance On NCD MCAC Referral Has Ongoing Comment Period

Industry reps plan to hold a conference call within the next several weeks to discuss a 1CMS draft guidance stipulating criteria for when national coverage determinations should be referred for external review or to the Medicare Coverage Advisory Committee

Draft Guidance On NCD MCAC Referral Has Ongoing Comment Period

Industry reps plan to hold a conference call within the next several weeks to discuss a 1CMS draft guidance stipulating criteria for when national coverage determinations should be referred for external review or to the Medicare Coverage Advisory Committee

CMS on deep-brain stimulation

National coverage determination for Parkinson's disease treatment expected by year-end, the agency states Nov. 4. The Medicare Coverage Advisory Committee executive committee previously voted for an NCD for bilateral deep-brain stimulation in a well-defined set of Parkinson's patients (1"The Gray Sheet" Sept. 30, 2002, p. 11)...

Related Content

UsernamePublicRestriction

Register

LL1135544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel